GlycoMimetics to Host 2018 Investor/Analyst Meeting at 60th ASH Annual Meeting on December 3, 2018
The investor/analyst event will be webcast beginning at
Investors/analysts are requested to pre-register for the private
in-person event at IR@glycomimetics.com.
The event will be held at
GlycoMimetics is a clinical-stage biotechnology company focused on the
discovery and development of novel glycomimetic drugs to address unmet
medical needs resulting from diseases in which carbohydrate biology
plays a key role.